Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Incyte Corp
(NQ:
INCY
)
65.12
-0.04 (-0.06%)
Streaming Delayed Price
Updated: 11:34 AM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Incyte Corp
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Incyte's Ruxolitinib Shows Further Improvement In Facial, Total Body Re-pigmentation At 52 Weeks In Skin Disorder
March 28, 2022
Incyte Corporation (NASDAQ: INCY)
Via
Benzinga
Incyte-Lilly's Olumiant Continue To Show Improved Scalp, Eyebrows, Eyelash Hair Regrowth At 52 Weeks
March 28, 2022
At the American Academy of Dermatology Annual Meeting, Eli Lilly And Co (NYSE: LLY) and Incyte Corp (NASDAQ: INCY)
Via
Benzinga
The Daily Biotech Pulse: Pfizer Reports Positive Ulcerative Colitis Study Data, Novavax COVID Shot Authorized For Adolescents In India, Argenx Stock Sale
March 23, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
MorphoSys-Incyte Partnered Minjuvi Temporarily Approved In Switzerland
March 23, 2022
The
Via
Benzinga
FDA Extends Decision Date For Incyte's Ruxolitinib In Vitiligo Skin Disorder
March 14, 2022
The FDA has extended the review period for Incyte Corporation's (NASDAQ: INCY) supplemental application for ruxolitinib cream (Opzelura) for vitiligo...
Via
Benzinga
Expert Ratings For Incyte
February 09, 2022
Incyte (NASDAQ:INCY) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Why Are Incyte Shares Trading Lower Today?
February 08, 2022
Incyte Corporation's (NASDAQ: INCY)
Via
Benzinga
Recap: Incyte Q4 Earnings
February 08, 2022
Incyte (NASDAQ:INCY) reported its Q4 earnings results on Tuesday, February 8, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Insiders Buy More Than $80M Of 3 Stocks
March 11, 2022
Although US stock futures traded higher this morning on Friday, there were a few notable insider trades.
Via
Benzinga
Why Are Company Insiders Buying These 7 S&P 500 Stocks?
March 08, 2022
Most investors are likely familiar with the adage, "actions speak louder than words." That saying certainly applies to the executives and other corporate insiders buying...
Via
Benzinga
Eli Lilly's JAK Inhibitor Baricitinib Cuts Death Risk By 13% In COVID-19 Patients
March 03, 2022
According to a British study, Eli Lilly And Co (NYSE: LLY) and Incyte Corporation's (NASDAQ: INCY) Olumiant (baricitinib) reduced the risk of death in...
Via
Benzinga
CTI BioPharma's Bone Marrow Cancer Drug Scores FDA Approval
March 01, 2022
The FDA approved CTI BioPharma Corp's (NASDAQ: CTIC) Vonjo (pacritinib) for treating adult patients with myelofibrosis, a type of bone marrow cancer with low...
Via
Benzinga
Insiders Buying Incyte And 2 More Stocks
February 23, 2022
Although U.S. stock futures traded higher this morning after recording losses on Tuesday, there were a few notable insider trades. When i...
Via
Benzinga
Eli Lilly Expects FDA Rejection For Expanded Use Baricitinib For Eczema
January 28, 2022
Based on top-line efficacy results from two pivotal Phase 3 trials Eli Lilly And Co (NYSE: LLY) has decided to
Via
Benzinga
Incyte Pulls Parsaclisib US Application For Lymphoma Treatment, Bows Out Solid Tumor Program With Merus
January 26, 2022
Incyte Corporation (NASDAQ: INCY) is
Via
Benzinga
Where Incyte Stands With Analysts
January 18, 2022
Within the last quarter, Incyte (NASDAQ:INCY) has observed the following an...
Via
Benzinga
7 Insider Stocks to Buy as Execs Snap Them Up
February 18, 2022
With equity prices soaring to record levels, many execs have cashed out. Here are the insider stocks where execs are cashing in.
Via
InvestorPlace
Insiders Buy Around $112M Of 3 Stocks
February 15, 2022
US stock futures traded higher on Tuesday, amid reports that some Russian troops are returning to their bases. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Oncolytics Announced Updates On Clinical Trials Of New Treatment For Triple-Negative Metastatic Breast Cancer
February 10, 2022
Image provided by Pexels This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 9, 2022
February 09, 2022
Upgrades According to Capital One, the prior rating for Federal Realty Investment Trust (NYSE:FRT) was changed from Equal-Weight to Overweight. Federal Realty Investment...
Via
Benzinga
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar
February 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Bear Market Bets In Biotech
February 07, 2022
Taken together, the SPDR S&P Biotech ETF easily broke below the long-term 200-week support for the first time since the pandemic originally hit the markets in March of 2020.
Via
Talk Markets
This Biotech Is Working With Pfizer, Merck KGaA, Roche, and Other Leaders To Develop a Better Standard of Care for Breast Cancer
January 13, 2022
Image provided by Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Cancer is the...
Via
Benzinga
Cramer Shares His Thoughts On Incyte, Corning And More
December 22, 2021
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Incyte Corporation (NASDAQ:
Via
Benzinga
Earnings Scheduled For February 8, 2022
February 08, 2022
Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.
Via
Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...
Via
Benzinga
4 Stocks Insiders Are Buying
December 20, 2021
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, t...
Via
Benzinga
Incyte's Topical JAK Inhibitor Under Priority FDA Review For Depigmented Skin Disorder
December 15, 2021
The FDA has accepted for review Incyte Corporation's (NASDAQ: INCY) supplemental marketing application seeking approval for ruxolitinib cream 1.5% (Opzelura), a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2022
January 18, 2022
Upgrades Canaccord Genuity upgraded the previous rating for Fortuna Silver Mines Inc (NYSE:
Via
Benzinga
Why Are Datadog, Zscaler, Airbnb, Fortinet, Lucid Trading Higher Premarket?
December 13, 2021
Airbnb, Inc (NASDAQ: ABNB), Fortinet, Inc (NASDAQ: FTNT), Palo Alto Networks, Inc (NASDAQ: PANW), Lucid Group, Inc (NASDAQ: LCID), Zscaler, Inc (NASDAQ: ZS), and Datadog, Inc (...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.